Header image

Oral Presentations 46: NAMS 1

Tracks
Track 6
Thursday, July 16, 2026
2:30 PM - 4:00 PM

Speaker

Agenda Item Image
Dr Enrico Mastrostefano
National Research Council

Integrating PBPK/PKPD with the C-Immsim Agent Based Model for TB therapy

Abstract

Biography

Agenda Item Image
Dr Emma Van der Westhuizen
St Vincent's Institute Of Medical Research

Bi-specific diabodies targeting β-amyloid to microglial phagocytic proteins for treating neurodegenerative diseases.

Abstract

Biography

Dr. Emma van der Westhuizen is a Senior Research Officer at St Vincent's Institute of Medical Research. She received her BSc (Hons) degree from the University of Melbourne (Australia) and her PhD from Monash University (Australia). She has completed post-doctoral research at the University of Montreal (Canada) and at Monash University (Australia), as an independently funded post-doctoral scholar (NHMRC, Australia; CIHR, Canada; FRSQ, Canada). Emma designs novel therapeutics to treat neurodegenerative diseases, within a collaborative multidisciplinary team. Emma strives to bridge the gap between research capabilities and clinical possibilities, by translating lead compounds from the developmental and experimental phases through to pre-clinical and clinical use.
Agenda Item Image
Dr Shivani Sachdev
National Institutes Of Health

Chimeric nanobody conjugates as tools for selective opioid receptor modulation

Abstract

Biography

Agenda Item Image
Prof Atsushi Yonezawa
Keio University

Mass spectrometry-based analysis of biotransformation in therapeutic antibodies

Abstract

Biography

Agenda Item Image
Dr Paris Papagianis
Monash University

Modeling acute silica-induced inflammation using precision-cut lung slices

Abstract

Biography

Agenda Item Image
Dr Sohini Chakraborty
Reva University

Comparative Machine Learning Analysis Predicts Breast Cancer Organ Tropism and Gene Signatures

Abstract

Biography

loading